Published in Diabetes on October 01, 1996
Postnatal leptin surge and regulation of circadian rhythm of leptin by feeding. Implications for energy homeostasis and neuroendocrine function. J Clin Invest (1998) 2.23
Effects of prolonged hyperinsulinemia on serum leptin in normal human subjects. J Clin Invest (1997) 1.17
Leptin secretion from adipose tissue in women. Relationship to plasma levels and gene expression. J Clin Invest (1997) 1.16
Synergistic effects of feeding and dexamethasone on serum leptin levels. J Clin Endocrinol Metab (1998) 0.95
25-Hydroxy vitamin-D, obesity, and associated variables as predictors of breast cancer risk and tamoxifen benefit in NSABP-P1. Breast Cancer Res Treat (2012) 0.94
Serum leptin concentrations are not related to dietary patterns but are related to sex, age, body mass index, serum triacylglycerol, serum insulin, and plasma glucose in the US population. Nutr Metab (Lond) (2009) 0.93
A pulse of insulin and dexamethasone stimulates serum leptin in fasting human subjects. Eur J Endocrinol (2002) 0.90
Leptin concentration in breast milk and its relationship to duration of lactation and hormonal status. Int Breastfeed J (2006) 0.89
Leptin signaling and Alzheimer's disease. Am J Neurodegener Dis (2012) 0.88
Elevated leptin expression in rat model of traumatic spinal cord injury and femoral fracture. J Spinal Cord Med (2011) 0.85
48-h glucose infusion in humans: effect on hormonal responses, hunger and food intake. Physiol Behav (2007) 0.84
Association of leptin genetic polymorphism -2548 G/A with gestational diabetes mellitus. Genes Nutr (2006) 0.83
Postnatal changes in concentrations of free and bound leptin. Arch Dis Child Fetal Neonatal Ed (2001) 0.82
Stimulation of leptin secretion by insulin. Indian J Endocrinol Metab (2012) 0.80
Paradoxical post-exercise responses of acylated ghrelin and leptin during a simulated night shift. Chronobiol Int (2010) 0.80
Counterregulation of insulin by leptin as key component of autonomic regulation of body weight. World J Diabetes (2014) 0.79
Variation in metabolic responses to meal challenges differing in glycemic index in healthy women: Is it meaningful? Nutr Metab (Lond) (2012) 0.77
Protective Effects of Ginger (Zingiber officinale) Extract against Diabetes-Induced Heart Abnormality in Rats. Diabetes Metab J (2016) 0.75
Use of the oral glucose tolerance test to assess insulin release and insulin sensitivity. Diabetes Care (2000) 4.14
Impaired glucose tolerance as a disorder of insulin action. Longitudinal and cross-sectional studies in Pima Indians. N Engl J Med (1988) 3.41
A common variant in PNPLA3, which encodes adiponutrin, is associated with liver fat content in humans. Diabetologia (2009) 3.33
Skeletal muscle capillary density and fiber type are possible determinants of in vivo insulin resistance in man. J Clin Invest (1987) 2.96
Overproduction of large VLDL particles is driven by increased liver fat content in man. Diabetologia (2006) 2.88
Efficacy and safety of sitagliptin when added to insulin therapy in patients with type 2 diabetes. Diabetes Obes Metab (2010) 2.30
Women and men have similar amounts of liver and intra-abdominal fat, despite more subcutaneous fat in women: implications for sex differences in markers of cardiovascular risk. Diabetologia (2004) 2.12
Kinetics of glucose disposal in whole body and across the forearm in man. J Clin Invest (1987) 1.83
Natural course of insulin resistance in type I diabetes. N Engl J Med (1986) 1.82
Hyperuricemia and insulin resistance. J Clin Endocrinol Metab (1994) 1.82
Hyperglycemia decreases glucose uptake in type I diabetes. Diabetes (1987) 1.58
Causes of weight gain during insulin therapy with and without metformin in patients with Type II diabetes mellitus. Diabetologia (1999) 1.58
Intramyocellular lipid is associated with resistance to in vivo insulin actions on glucose uptake, antilipolysis, and early insulin signaling pathways in human skeletal muscle. Diabetes (2001) 1.57
Serum saturated fatty acids containing triacylglycerols are better markers of insulin resistance than total serum triacylglycerol concentrations. Diabetologia (2009) 1.53
Defective regulation of triglyceride metabolism by insulin in the liver in NIDDM. Diabetologia (1997) 1.49
Insulin increases the release of endothelin in endothelial cell cultures in vitro but not in vivo. Metabolism (1994) 1.42
Hyperreactivity to nitrovasodilators in forearm vasculature is related to autonomic dysfunction in insulin-dependent diabetes mellitus. Circulation (1997) 1.41
Independent influence of age on basal insulin secretion in nondiabetic humans. European Group for the Study of Insulin Resistance. J Clin Endocrinol Metab (1999) 1.37
Activation of the hexosamine pathway by glucosamine in vivo induces insulin resistance of early postreceptor insulin signaling events in skeletal muscle. Diabetes (1999) 1.37
Physical training and insulin sensitivity. Diabetes Metab Rev (1986) 1.37
Acute suppression of VLDL1 secretion rate by insulin is associated with hepatic fat content and insulin resistance. Diabetologia (2007) 1.34
Tissue specificity of insulin resistance in humans: fat in the liver rather than muscle is associated with features of the metabolic syndrome. Diabetologia (2007) 1.31
Gender and insulin sensitivity in the heart and in skeletal muscles. Studies using positron emission tomography. Diabetes (1995) 1.30
Insulin resistance, hyperinsulinemia, and blood pressure: role of age and obesity. European Group for the Study of Insulin Resistance (EGIR). Hypertension (1997) 1.30
Chronic hyperglycemia impairs endothelial function and insulin sensitivity via different mechanisms in insulin-dependent diabetes mellitus. Circulation (1996) 1.26
Regulation of glycogen synthase and phosphorylase activities by glucose and insulin in human skeletal muscle. J Clin Invest (1987) 1.25
Methodological aspects, dose-response characteristics and causes of interindividual variation in insulin stimulation of limb blood flow in normal subjects. Diabetologia (1995) 1.25
Insulin regulates the serum levels of low molecular weight insulin-like growth factor-binding protein. J Clin Endocrinol Metab (1988) 1.22
Metabolic basis of hypotriglyceridemic effects of insulin in normal men. Arterioscler Thromb Vasc Biol (1997) 1.17
Insulin increases plasma leptin concentrations in normal subjects and patients with NIDDM. Diabetologia (1996) 1.16
Intense physical training decreases circulating antioxidants and endothelium-dependent vasodilatation in vivo. Atherosclerosis (1999) 1.16
Sex and insulin sensitivity. Metabolism (1984) 1.13
Effects of insulin and acipimox on VLDL1 and VLDL2 apolipoprotein B production in normal subjects. Diabetes (1998) 1.11
Insulin therapy induces antiatherogenic changes of serum lipoproteins in noninsulin-dependent diabetes. Arteriosclerosis (1988) 1.11
Differential effects of oral and transdermal estrogen replacement therapy on endothelial function in postmenopausal women. Circulation (2000) 1.10
In vivo endothelial dysfunction characterizes patients with impaired fasting glucose. Diabetes Care (1999) 1.09
Role of blood flow in regulating insulin-stimulated glucose uptake in humans. Studies using bradykinin, [15O]water, and [18F]fluoro-deoxy-glucose and positron emission tomography. J Clin Invest (1996) 1.07
Free fatty acid kinetics and oxidation in congestive heart failure. Am J Cardiol (1998) 1.07
Expression of fatty-acid-handling proteins in human adipose tissue in relation to obesity and insulin resistance. Diabetologia (2004) 1.06
Continuous subcutaneous insulin infusion therapy decreases insulin resistance in type 1 diabetes. J Clin Endocrinol Metab (1984) 1.05
Level of skeletal muscle glucose transporter protein correlates with insulin-stimulated whole body glucose disposal in man. Diabetologia (1991) 1.05
Effects of oral and transdermal estrogen replacement therapy on markers of coagulation, fibrinolysis, inflammation and serum lipids and lipoproteins in postmenopausal women. Thromb Haemost (2001) 1.05
Insulin sensitivity in newly diagnosed type 1 diabetics after ketoacidosis and after three months of insulin therapy. J Clin Endocrinol Metab (1984) 1.02
Portal insulin concentrations rather than insulin sensitivity regulate serum sex hormone-binding globulin and insulin-like growth factor binding protein 1 in vivo. J Clin Endocrinol Metab (1995) 1.01
Exenatide treatment did not affect bone mineral density despite body weight reduction in patients with type 2 diabetes. Diabetes Obes Metab (2011) 1.00
Myocardial oxygen consumption is unchanged but efficiency is reduced in patients with essential hypertension and left ventricular hypertrophy. Circulation (1999) 0.99
Diminished wave reflection in the aorta. A novel physiological action of insulin on large blood vessels. Hypertension (1999) 0.99
Fructose and insulin sensitivity in patients with type 2 diabetes. J Intern Med (1993) 0.99
Postprandial metabolism of apolipoprotein B-48- and B-100-containing particles in type 2 diabetes mellitus: relations to angiographically verified severity of coronary artery disease. Atherosclerosis (2000) 0.98
Insulin resistance characterizes glucose uptake in skeletal muscle but not in the heart in NIDDM. Diabetologia (1998) 0.98
Mechanisms of insulin resistance during acute endotoxemia. Endocrinology (1994) 0.98
Insulin sensitivity during the menstrual cycle. J Clin Endocrinol Metab (1984) 0.97
Impaired endothelium-dependent vasodilation in type 2 diabetes. Relation to LDL size, oxidized LDL, and antioxidants. Diabetes Care (1999) 0.97
Relationship between limb and muscle blood flow in man. J Physiol (1996) 0.97
Inhibition of lipolysis decreases lipid oxidation and gluconeogenesis from lactate but not fasting hyperglycemia or total hepatic glucose production in NIDDM. Diabetes (1993) 0.97
Apoprotein E polymorphism and coronary artery disease. Increased prevalence of apolipoprotein E-4 in angiographically verified coronary patients. Arteriosclerosis (1989) 0.96
Acute in vivo effects of insulin on gene expression in adipose tissue in insulin-resistant and insulin-sensitive subjects. Diabetologia (2005) 0.96
Gene expression and immunohistochemistry in adipose tissue of HIV type 1-infected patients with nucleoside analogue reverse-transcriptase inhibitor-associated lipoatrophy. J Infect Dis (2009) 0.95
Effects of body composition on insulin sensitivity. Diabetes (1983) 0.95
No reduction in total hepatic glucose output by inhibition of gluconeogenesis with ethanol in NIDDM patients. Diabetes (1991) 0.95
Inaccuracies in food and physical activity diaries of obese subjects: complementary evidence from doubly labeled water and co-twin assessments. Int J Obes (Lond) (2009) 0.95
Activation of the hexosamine pathway by glucosamine in vivo induces insulin resistance in multiple insulin sensitive tissues. Endocrinology (1997) 0.95
Normalization of insulin sensitivity in type I diabetic subjects by physical training during insulin pump therapy. Diabetes Care (1985) 0.95
Endothelial dysfunction in men with small LDL particles. Circulation (2000) 0.94
Dietary supplementation with n-3 fatty acids increases gluconeogenesis from glycerol but not hepatic glucose production in patients with non-insulin-dependent diabetes mellitus. Am J Clin Nutr (1995) 0.94
Dose-response characteristics for suppression of low molecular weight plasma insulin-like growth factor-binding protein by insulin. J Clin Endocrinol Metab (1989) 0.94
Insulin therapy improves endothelial function in type 2 diabetes. Arterioscler Thromb Vasc Biol (2000) 0.93
Effect of antilipolysis on heart and skeletal muscle glucose uptake in overnight fasted humans. Am J Physiol (1994) 0.93
Effect of insulin on GLUT-4 mRNA and protein concentrations in skeletal muscle of patients with NIDDM and their first-degree relatives. Diabetologia (1994) 0.93
Ethanol decreases glucose utilization in healthy man. J Clin Endocrinol Metab (1985) 0.93
Increased augmentation of central blood pressure is associated with increases in carotid intima-media thickness in type 2 diabetic patients. Diabetologia (2005) 0.92
Lipolysis and gluconeogenesis from glycerol are increased in patients with noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab (1992) 0.92
Insulin resistance is a prominent feature of patients with pancreatogenic diabetes. Metabolism (1986) 0.92
Intact insulin stimulation of skeletal muscle blood flow, its heterogeneity and redistribution, but not of glucose uptake in non-insulin-dependent diabetes mellitus. J Clin Invest (1997) 0.92
Hyperglycaemia is associated with changes in the regional concentrations of glucose and myo-inositol within the brain. Diabetologia (2008) 0.92
Insulin secretion and insulin sensitivity in people with impaired glucose tolerance. Diabet Med (1996) 0.91
Glucose and lipid metabolism and insulin sensitivity in type 1 diabetes: the effect of guar gum. Am J Clin Nutr (1988) 0.90
UDP-N-acetylglucosamine transferase and glutamine: fructose 6-phosphate amidotransferase activities in insulin-sensitive tissues. Diabetologia (1997) 0.90
Pathogenesis and prevention of the dawn phenomenon in diabetic patients treated with CSII. Diabetes (1986) 0.90
Resistance to acute insulin induced decreases in large artery stiffness accompanies the insulin resistance syndrome. J Clin Endocrinol Metab (2001) 0.90
The effect of insulin and FFA on myocardial glucose uptake. J Mol Cell Cardiol (1995) 0.90
Allosteric regulation of glycogen synthase and hexokinase by glucosamine-6-phosphate during glucosamine-induced insulin resistance in skeletal muscle and heart. Diabetes (1999) 0.90
In the lipodystrophy associated with highly active antiretroviral therapy, pseudo-Cushing's syndrome is associated with increased regeneration of cortisol by 11beta-hydroxysteroid dehydrogenase type 1 in adipose tissue. Diabetologia (2004) 0.89
Predictors of abnormal cardiovascular autonomic function measured by frequence domain analysis of heart rate variability and conventional tests in patients with type 1 diabetes. Diabetes Care (2000) 0.89
Metformin prevents weight gain by reducing dietary intake during insulin therapy in patients with type 2 diabetes mellitus. Drugs (1999) 0.88
Dissociation of in vitro sensitivities of glucose transport and antilipolysis to insulin in NIDDM. Am J Physiol (1987) 0.88
Addition of insulin glargine or NPH insulin to metformin monotherapy in poorly controlled type 2 diabetic patients decreases IGF-I bioactivity similarly. Diabetologia (2012) 0.88
Insulin action on heart and skeletal muscle glucose uptake in weight lifters and endurance athletes. Am J Physiol (1999) 0.87
Increased glutamine:fructose-6-phosphate amidotransferase activity in skeletal muscle of patients with NIDDM. Diabetes (1996) 0.87
Different alterations in the insulin-stimulated glucose uptake in the athlete's heart and skeletal muscle. J Clin Invest (1994) 0.87
Mechanisms of hepatic and peripheral insulin resistance during acute infections in humans. J Clin Endocrinol Metab (1992) 0.87
Enhancement of myocardial [fluorine-18]fluorodeoxyglucose uptake by a nicotinic acid derivative. J Nucl Med (1994) 0.86
Insulin-induced decrease in large artery stiffness is impaired in uncomplicated type 1 diabetes mellitus. Hypertension (2000) 0.86